Difference between revisions of "Team:UPMC PARIS/State of art"

Line 2: Line 2:
 
<html>
 
<html>
  
 +
sustain the future vaccination campaigns and ensure the sustainability of the treatments.
 +
        <br>http://www.who.int/mediacentre/news/releases/2017/global-hepatitis-report/fr/
  
−
<div class="column full_size judges-will-not-evaluate">
+
        <br><br>
−
<h3>★  ALERT! </h3>
+
−
<p>This page is used by the judges to evaluate your team for the <a href="https://2017.igem.org/Judging/Medals">medal criterion</a> or <a href="https://2017.igem.org/Judging/Awards"> award listed above</a>. </p>
+
−
<p> Delete this box in order to be evaluated for this medal criterion and/or award. See more information at <a href="https://2017.igem.org/Judging/Pages_for_Awards"> Instructions for Pages for awards</a>.</p>
+
−
</div>
+
−
<div class="clear"></div>
+
  
−
<div class="column full_size">
+
        <h4>Conclusion</h4>
−
<h1>Improve</h1>
+
        <p>
−
<p>For teams seeking to improve upon a previous part or project, you should document all of your work on this page. Please remember to include all part measurement and characterization data on the part page on the Regisrty. Please include a link to your improved part on this page.</p>
+
  
−
<h3>Gold Medal Criterion #2</h3>
+
          Following the example of overall infections, the lack of serotherapy as a treatment for these infectious diseases takes part in the significant mortality caused by a lack to medicines. In addition, maternal mortality also mainly affects middle-income countries, whose inhabitants cannot afford the necessary treatments. The isolation from health establishments also plays an important role in the lack of medical care for pregnancy in these regions of the world.
−
<p><b>Standard Tracks:</b> Improve the function of an existing BioBrick Part. The original part must NOT be from your 2017 part number range. If you change the original part sequence, you must submit a new part. In addition, both the new and original part pages must reference each other. This working part must be different from the part documented in bronze #4 and silver #1.
+
  
−
<br><br>
+
        </p>
−
<b>Special Tracks:</b> Improve the function of an existing iGEM project (that your current team did not originally create) and display your achievement on your wiki.</p>
+
  
 +
      </p>
 +
          </div><!-- col-lg -->
 +
  </div><!-- row -->
  
−
</div>
 
  
 +
    <div id="footerwrap">
  
 +
    <style media="screen">
 +
    #footerwrap {
 +
      background: #ffffff;
 +
      color: black;
 +
    }
 +
    #footerwrap h4,#footerwrap h3{
 +
      color: black;
 +
    }
 +
    </style>
  
 +
    <div class="container">
 +
      <div class="col-sm-12">
 +
        <br>
 +
        <h3>Sponsors</h3>
 +
        <br><br><br>
 +
        <div class="row">
 +
          <div class="col-sm-3">
 +
            <img height="40%" width="40%" src="sponsors/UPMC_team_2017_sponsors_FSDIE.jpg" alt="">
 +
          </div>
 +
          <div class="col-sm-3">
 +
            <img height="30%" width="30%" src="sponsors/UPMC_team_2017_sponsors_Ambassade_france.jpg" alt="">
 +
          </div>
 +
          <div class="col-sm-3">
 +
            <img height="30%" width="30%" src="sponsors/UPMC_team_2017_sponsors_Bagneux.jpg" alt="">
 +
          </div>
 +
          <div class="col-sm-3">
 +
            <img height="30%" width="30%" src="sponsors/UPMC_team_2017_sponsors_ICM.png" alt="">
 +
          </div>
 +
        </div>
 +
        <br>
 +
        <div class="row">
 +
          <div class="col-sm-3">
 +
            <img height="60%" width="60%" src="sponsors/UPMC_team_2017_sponsors_UPMC.png" alt="">
 +
          </div>
 +
          <div class="col-sm-3">
 +
            <img height="30%" width="30%" src="sponsors/UPMC_team_2017_sponsors_IDT.png" alt="">
 +
          </div>
 +
          <div class="col-sm-3">
 +
            <img height="30%" width="30%" src="sponsors/UPMC_team_2017_sponsors_NEB.png" alt="">
 +
          </div>
 +
          <div class="col-sm-3">
 +
            <img height="50%" width="50%" src="sponsors/UPMC_team_2017_sponsors_T-Evry_Paris-Saclay-logos-sponsors-sigma.png" alt="">
 +
          </div>
 +
        </div>
 +
        <br>
 +
        <div class="row">
 +
          <div class="col-sm-3">
 +
            <img src="sponsors/UPMC_team_2017_sponsors_CFA_UPMC.png" alt="">
 +
          </div>
 +
          <div class="col-sm-3">
 +
            <img height="40%" width="40%" src="sponsors/UPMC_team_2017_sponsors_Valenton.png" alt="">
 +
          </div>
 +
          <div class="col-sm-2">
 +
            <img height="100%" width="100%" src="sponsors/UPMC_team_2017_sponsors_Logo_Paillasse.jpg" alt="">
 +
          </div>
 +
          <div class="col-sm-2">
 +
            <img height="100%" width="100%" src="sponsors/UPMC_team_2017_sponsors_MAster_BMC.jpg" alt="">
 +
          </div>
 +
          <div class="col-sm-2">
 +
            <img height="100%" width="100%" src="sponsors/UPMC_team_2017_sponsors_UFR_bio.jpg" alt="">
 +
          </div>
 +
        </div>
 +
      </div>
 +
 +
    </div>
 +
  </div>
 +
 +
</body>
 
</html>
 
</html>

Revision as of 00:54, 15 December 2017

Impact UPMC

sustain the future vaccination campaigns and ensure the sustainability of the treatments.
http://www.who.int/mediacentre/news/releases/2017/global-hepatitis-report/fr/

Conclusion

Following the example of overall infections, the lack of serotherapy as a treatment for these infectious diseases takes part in the significant mortality caused by a lack to medicines. In addition, maternal mortality also mainly affects middle-income countries, whose inhabitants cannot afford the necessary treatments. The isolation from health establishments also plays an important role in the lack of medical care for pregnancy in these regions of the world.


Sponsors